down arrow

Halozyme Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US40637H1095
  • NASDAQ: HALO
USD
112.44
-2.69 (-2.34%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryHalozyme Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
calendar-icon
calendar-icon
1D
-2.34%
-0.75%
1W
3.69%
2.04%
1M
3.95%
0.41%
YTD
67.07%
12.57%
1Y
44.95%
15.76%
3Y
184.15%
78.38%
5Y
167.91%
73.21%
10Y
830.02%
255.99%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
61.51%
0%
61.51%
6 Months
78.87%
0%
78.87%
1 Year
44.95%
0%
44.95%
2 Years
92.11%
0%
92.11%
3 Years
184.15%
0%
184.15%
4 Years
189.64%
0%
189.64%
5 Years
167.91%
0%
167.91%

Halozyme Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading